CIK 0001682852
- Large accelerated filer
Moderna, Inc.
Sign in to watch- Ticker
- MRNA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 813467528
- Phone
- +1 617-714-6500
- Business address
- 325 BINNEY STREET, CAMBRIDGE, MA, 02142
- Former names
- Moderna Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $50,775,837
- in 5 filings, $50.8M under 10b5-1 plans
Net −$50,775,837. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Sale | −700 | $202.35 | $142K | 5,451,246 |
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Sale | −6,216 | $203.56 | $1.3M | 5,445,030 |
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Sale | −8,379 | $204.47 | $1.7M | 5,436,651 |
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Sale | −11,981 | $205.50 | $2.5M | 5,424,670 |
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Sale | −9,093 | $206.39 | $1.9M | 5,415,577 |
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Sale | −2,872 | $207.33 | $595K | 5,412,705 |
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Sale | −759 | $208.13 | $158K | 5,411,946 |
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Sale | −10,000 | $209.82 | $2.1M | 6,574,880 |
| 2022-12-22 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 2,107,155 | ||
| 2022-12-21 | Bancel Stephane Chief Executive Officer | Exercise or conversion | +40,000 | $0.99 | $40K | 5,451,946 |
| 2022-12-21 | Bancel Stephane Chief Executive Officer | Sale | −6,500 | $203.46 | $1.3M | 5,445,446 |
| 2022-12-21 | Bancel Stephane Chief Executive Officer | Sale | −3,183 | $205.51 | $654K | 5,442,263 |
| 2022-12-21 | Bancel Stephane Chief Executive Officer | Sale | −5,775 | $206.64 | $1.2M | 5,436,488 |
| 2022-12-21 | Bancel Stephane Chief Executive Officer | Sale | −8,833 | $207.46 | $1.8M | 5,427,655 |
| 2022-12-21 | Bancel Stephane Chief Executive Officer | Sale | −11,131 | $208.66 | $2.3M | 5,416,524 |
| 2022-12-21 | Bancel Stephane Chief Executive Officer | Sale | −4,307 | $209.30 | $901K | 5,412,217 |
| 2022-12-21 | Bancel Stephane Chief Executive Officer | Sale | −271 | $210.16 | $57K | 5,411,946 |
| 2022-12-21 | Bancel Stephane Chief Executive Officer | Exercise or conversion · Stock Option (Right to Buy) | −40,000 | 2,147,155 | ||
| 2022-12-21 | Andres Juan | Exercise or conversion | +2,000 | $20.93 | $42K | 14,803 |
Page 63 of 66 · 1,314 trades